There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Monogram Orthopaedics Inc (MGRM – Research ...
Hosted on MSN14d
MGRM: Monogram’s Potential for 2025 Commercialization of its mBôs Total Knee Arthroplasty Robotic System Supports Price Target of $6.00.MGRM READ THE FULL MGRM RESEARCH REPORT Regulatory Update On February 26, 2025, Monogram (NASDAQ:MGRM) announced an update regarding its 510(k) premarket filing submission to the FDA for the company's ...
Value-based care providers have increasingly collaborated with health insurers to try and keep medically complex patients out ...
Partnership will expand access to high-quality in-home care for patients in Southeast Texas with multiple chronic conditionsNASHVILLE, Te ...
A video demonstrating these next-gen improvements is available below. Dr. Douglas Unis, Monogram's Chief Medical Officer, commented, "The latest advancements in Monogram's robotic system are a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback